NoviPet Joint Support 500 mg / 500 mg / 50 mg / 5 mg Chewable Tablet
RxNorm 1236148

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 1236148 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: NoviPet Joint Support 500 mg / 500 mg / 50 mg / 5 mg Chewable Tablet.

The following semantic concepts and normalized strings are associated with this clinical entity:

SBD
Chondroitin sulfates 50 mg / glucosamine sulfate 500 mg / methylsulfonylmethane 500 mg / tocopherol 5 mg Chewable Tablet [Novipet Joint Support]
AUI:12367852
SY
Novipet Joint Support (chondroitin sulfates 50 mg / glucosamine sulfate 500 mg / MSM 500 mg / vitamin E 5 mg) Chewable Tablet
AUI:4227324
PSN
NoviPet Joint Support 500 mg / 500 mg / 50 mg / 5 mg Chewable Tablet
AUI:6365984

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

SBD

Semantic Branded Drug (SBD):
Chondroitin sulfates 50 mg / glucosamine sulfate 500 mg / methylsulfonylmethane 500 mg / tocopherol 5 mg Chewable Tablet [Novipet Joint Support]
(Atom ID: 12367852)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
chondroitin sulfates 50 MG / glucosamine sulfate 500 MG / methylsulfonylmethane 500 MG / tocopherol 5 MG Chewable Tablet [Novipet Joint Support]
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1236148
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12367852
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SBD
Semantic Branded Drug (Ingredient + Strength + Dose Form + Brand Name)
Source Code
1236148
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Technical Attributes & Logic

RXN AI
{1236135} 2473
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{1236137} 1236136
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{331697} 4847
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{340500} 23247
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AM
{1236135} 2473
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{1236137} 1236136
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{331697} 4845
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{340500} 23247
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{1236135} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{1236137} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{331697} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{340500} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN VET DRUG
US
Drug available for use in animals
RXTERM FORM
Tab
The RxTerm dose form name for this drug

SY

Synonym (SY):
Novipet Joint Support (chondroitin sulfates 50 mg / glucosamine sulfate 500 mg / MSM 500 mg / vitamin E 5 mg) Chewable Tablet
(Atom ID: 4227324)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
Novipet Joint Support (chondroitin sulfates 50 MG / glucosamine sulfate 500 MG / MSM 500 MG / vitamin E 5 MG) Chewable Tablet
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1236148
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
4227324
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SY
Synonym (Synonym of another TTY, given for clarity.)
Source Code
1236148
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

PSN

Prescribable Name (PSN):
NoviPet Joint Support 500 mg / 500 mg / 50 mg / 5 mg Chewable Tablet
(Atom ID: 6365984)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
NoviPet Joint Support 500 MG / 500 MG / 50 MG / 5 MG Chewable Tablet
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1236148
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
6365984
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
PSN
Prescribable Name (Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.)
Source Code
1236148
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Patient Education

Methylsulfonylmethane (MSM)


What is it? Methylsulfonylmethane (MSM) is a chemical found in green plants, animals, and humans. It can also be made in a laboratory.

Some literature that promotes MSM states that MSM can treat sulfur deficiency. But there is no Recommended Dietary Allowance (RDA) for MSM or sulfur, and sulfur deficiency has not been described in the medical literature.

People use MSM for osteoarthritis. It is also used for pain, swelling, aging skin, and many other conditions, but there is no good scientific evidence to support most of these uses.


[Learn More]


* Please review the disclaimer below.